Suppr超能文献

细胞毒性T淋巴细胞对体外选择的H-2Kb突变体上表达的新型同种异体决定簇的识别。

Cytotoxic T lymphocyte recognition of novel allodeterminants expressed on in vitro selected H-2Kb mutants.

作者信息

Lewis J, Foo M, Geier S S, Kumar P A, Nathenson S G, Bluestone J A

机构信息

Transplantation Biology Section, National Cancer Institute, Bethesda, MD 20892.

出版信息

J Immunol. 1988 Aug 1;141(3):728-35.

PMID:2456331
Abstract

In the present study, in vitro derived H-2Kb mutants have been examined by alloreactive CTL. Two mutants, R8.24 and R8.246, have been shown to express novel determinants detected by CTL generated against some but not all in vivo derived Kb mutants. BDF1 anti-bm3, anti-bm11, anti-bm19, anti-bm23, and anti-bm6 CTL populations lyse the two R8 variants. The novel determinants expressed on the R8 mutants detected by the bm3 and bm23-specific CTL appear to differ from the determinant recognized by the bm6-specific CTL. No new serologically defined determinants were detected on any of 18 independent R8 variants. However, these results do not rule out the existence of new determinants which could be recognized by antibodies. Finally, the relationship between the T cell recognition of the in vivo and in vitro derived mutants and their use in understanding the structure/function relationships between the immune response and class I Ag based on recent crystallographic analyses is discussed.

摘要

在本研究中,体外衍生的H-2Kb突变体已通过同种反应性CTL进行检测。已证明两个突变体R8.24和R8.246表达了由针对某些但并非所有体内衍生的Kb突变体产生的CTL检测到的新决定簇。BDF1抗bm3、抗bm11、抗bm19、抗bm23和抗bm6 CTL群体可裂解这两个R8变体。由bm3和bm23特异性CTL检测到的R8突变体上表达的新决定簇似乎与bm6特异性CTL识别的决定簇不同。在18个独立的R8变体中均未检测到新的血清学定义的决定簇。然而,这些结果并不排除存在可被抗体识别的新决定簇。最后,基于最近的晶体学分析,讨论了体内和体外衍生突变体的T细胞识别之间的关系及其在理解免疫反应与I类抗原之间的结构/功能关系中的应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验